Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
Condition:   Plaque Psoriasis Interventions:   Biological: Ixekizumab;   Drug: Methotrexate;   Drug: Cyclosporin A;   Drug: Acitretin Sponsors:   Singapore General Hospital;   Translational Immunology Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 3, 2020 Category: Research Source Type: clinical trials